Trial Profile
Phase I/II Study of Ixazomib in Combination With Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients With Double Refractory Multiple Myeloma
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Clarithromycin (Primary) ; Dexamethasone (Primary) ; Ixazomib (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 22 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 10 Sep 2015 New trial record